Immunosuppression underlies resistance to anti-angiogenic therapy

(Massachusetts General Hospital) A Massachusetts General Hospital research team has identified a novel mechanism behind resistance to angiogenesis inhibitors -- drugs that fight cancer by suppressing the formation of new blood vessels.